BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 9108934)

  • 1. Leukemogenesis by Moloney murine leukemia virus: a multistep process.
    Fan H
    Trends Microbiol; 1997 Feb; 5(2):74-82. PubMed ID: 9108934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multistep process of leukemogenesis in Moloney murine leukemia virus-infected mice that is modulated by retroviral pseudotyping and interference.
    Lavignon M; Evans L
    J Virol; 1996 Jun; 70(6):3852-62. PubMed ID: 8648721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate detectable mink cell focus-inducing virus in vivo.
    Brightman BK; Rein A; Trepp DJ; Fan H
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2264-8. PubMed ID: 2006167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
    Brightman BK; Okimoto M; Kulkarni V; Lander JK; Fan H
    Virology; 1998 Mar; 242(1):60-7. PubMed ID: 9501051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation.
    Belli B; Patel A; Fan H
    J Virol; 1995 Feb; 69(2):1037-43. PubMed ID: 7815481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early (preleukemic) events in Moloney murine leukemia virus leukemogenesis.
    Fan H; Brightman BK; Belli B; Okimoto M; Tao M
    Leukemia; 1997 Apr; 11 Suppl 3():149-51. PubMed ID: 9209326
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiation leukemia virus-induced leukemogenesis: a paradigm of preleukemia and its control by preventive therapy.
    Yefenof E; Kotler M
    Adv Cancer Res; 1995; 66():293-312. PubMed ID: 7793318
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of a preleukemic state induced by Moloney murine leukemia virus: evidence for two infection events during leukemogenesis.
    Davis BR; Brightman BK; Chandy KG; Fan H
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4875-9. PubMed ID: 3474632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
    Brightman BK; Farmer C; Fan H
    J Virol; 1993 Dec; 67(12):7140-8. PubMed ID: 8230436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appearance of mink cell focus-inducing recombinants during in vivo infection by moloney murine leukemia virus (M-MuLV) or the Mo+PyF101 M-MuLV enhancer variant: implications for sites of generation and roles in leukemogenesis.
    Lander JK; Chesebro B; Fan H
    J Virol; 1999 Jul; 73(7):5671-80. PubMed ID: 10364317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the LTR region between the enhancer and promoter in mink cell focus-forming murine leukemia virus pathogenesis.
    Yoshimura FK; Wang T
    Virology; 2001 Apr; 283(1):121-31. PubMed ID: 11312668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses.
    Ishimoto A; Takimoto M; Adachi A; Kakuyama M; Kato S; Kakimi K; Fukuoka K; Ogiu T; Matsuyama M
    J Virol; 1987 Jun; 61(6):1861-6. PubMed ID: 3033317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The leukemogenic potential of an enhancer variant of Moloney murine leukemia virus varies with the route of inoculation.
    Belli B; Fan H
    J Virol; 1994 Nov; 68(11):6883-9. PubMed ID: 7933068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukaemogenesis by the delta Mo + SV Moloney murine leukaemia virus (M-MuLV) variant in E mu pim-1 transgenic mice: high frequency of recombination with a solo endogenous M-MuLV LTR in vivo.
    Suchman EL; Pattengale PK; Fan H
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():347-56. PubMed ID: 7844555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gross murine leukemia virus-induced alterations in the thymus of preleukemic AKR mice.
    Beardsley TR; Hays EF
    Cancer Res; 1979 Feb; 39(2 Pt 1):480-6. PubMed ID: 32967
    [No Abstract]   [Full Text] [Related]  

  • 17. Moloney murine leukemia virus-induced preleukemic thymic atrophy and enhanced thymocyte apoptosis correlate with disease pathogenicity.
    Bonzon C; Fan H
    J Virol; 1999 Mar; 73(3):2434-41. PubMed ID: 9971828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the spleen in preleukemic development of a murine retrovirus-induced promonocytic leukemia.
    Nason-Burchenal K; Wolff L
    Cancer Res; 1992 Oct; 52(19):5317-22. PubMed ID: 1394137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined infection by Moloney murine leukemia virus and a mink cell focus-forming virus recombinant induces cytopathic effects in fibroblasts or in long-term bone marrow cultures from preleukemic mice.
    Li QX; Fan H
    J Virol; 1990 Aug; 64(8):3701-11. PubMed ID: 2164592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral gene insertion in breast milk mediated lymphomagenesis.
    Chakraborty J; Okonta H; Bagalb H; Lee SJ; Fink B; Changanamkandat R; Duggan J
    Virology; 2008 Jul; 377(1):100-9. PubMed ID: 18501945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.